TESARO Announces Participation at Two Investor Conferences

WALTHAM, Mass., Feb. 21, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences are:

  • The Raymond James 38th Annual Institutional Investors Conference at the JW Marriott Grand Lakes in Orlando, Florida on Monday, March 6, 2017. Tim Pearson, EVP and CFO of TESARO, will present at 8:40 AM ET and participate in meetings with investors.
     
  • The Barclays Global Healthcare Conference at the Loews Hotel in Miami, Florida on Wednesday, March 15, 2017. Lonnie Moulder, CEO of TESARO, will participate in an analyst-led moderated Q&A from 3:50 to 4:15 PM ET and in meetings with investors.

Live webcasts of the presentations at the Raymond James and Barclays conferences will be available by visiting the Investors section of the TESARO website at www.tesarobio.com. Archived replays of these webcasts will be available on the Company’s website for 14 days following the conferences.

About TESARO
TESARO is an oncology-focused biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. For more information, visit www.tesarobio.com, and follow us on Twitter and LinkedIn.

CONTACT: For additional information, please contact:     
Jennifer Davis
1.781.325.1116
jdavis@tesarobio.com

Ads

You May Also Like

Athenex Announces Recent Product Launches in Commercial Business

BUFFALO, N.Y., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical ...

Merit Medical to Participate at Three Conferences

Canaccord Genuity – November 9Jefferies – November 16Piper Jaffray – November 29 SOUTH JORDAN, ...